Cargando…

Safety of Surgery after Neoadjuvant Targeted Therapies in Non-Small Cell Lung Cancer: A Narrative Review

New drugs, including immune checkpoint inhibitors and targeted therapy, have changed the prognosis in a subset of patients with advanced lung cancer, and are now actively investigated in a number of trials with neoadjuvant and adjuvant regimens. However, no phase III randomized studies were publishe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marjanski, Tomasz, Dziedzic, Robert, Kowalczyk, Anna, Rzyman, Witold
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622767/ https://www.ncbi.nlm.nih.gov/pubmed/34830123 http://dx.doi.org/10.3390/ijms222212244

Ejemplares similares

A narrative review of invasive diagnostics and treatment of early lung cancer
por: Dziedzic, Robert, et al.
Publicado: (2021)

Trimodality Treatment of Superior Sulcus Non-Small Cell Lung Cancer: An Institutional Series of 47 Consecutive Patients
por: Rzyman, Witold, et al.
Publicado: (2023)

Younger patients operated for lung cancer have a better prognosis
por: Marjanski, Tomasz, et al.
Publicado: (2020)

Physiological Biomarkers Assessed by Low-Tech Exercise Tests Predict Complications and Overall Survival in Patients Undergoing Pneumonectomy Due to Lung Cancer
por: Marjanski, Tomasz, et al.
Publicado: (2021)

500 Meters Is a Result of 6-Minute Walk Test Which Differentiates Patients with High and Low Risk of Postoperative Complications after Lobectomy—A Validation Study
por: Marjanski, Tomasz, et al.
Publicado: (2021)

Catamenial pneumothorax – a review of the literature
por: Marjański, Tomasz, et al.
Publicado: (2016)

Performance of various risk prediction models in a large lung cancer screening cohort in Gdańsk, Poland—a comparative study
por: Ostrowski, Marcin, et al.
Publicado: (2021)

Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours
por: Chruściel, Elżbieta, et al.
Publicado: (2020)

Incidentally diagnosed pulmonary nodule: a diagnostic algorithm
por: Dziedzic, Robert, et al.
Publicado: (2014)

Neoadjuvant immunotherapy in non-small cell lung cancer: a narrative review on mechanisms, efficacy and safety
por: Shao, Lan, et al.
Publicado: (2022)

What Inhibits Natural Killers’ Performance in Tumour
por: Papak, Ines, et al.
Publicado: (2022)

Editorial on implementation of CT-based screening of lung cancer
por: Rzyman, Witold
Publicado: (2021)

Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer. A Narrative Review
por: Gatteschi, Lavinia, et al.
Publicado: (2021)

Comprehensive study of neoadjuvant targeted therapy for resectable non-small cell lung cancer
por: Bao, Yi, et al.
Publicado: (2021)

Lung exposure during simultaneous myocardial revascularization and lung surgery through median sternotomy
por: Jagielak, Dariusz, et al.
Publicado: (2016)

Bayesian network meta-analysis of efficacy and safety of neoadjuvant therapy for non-small-cell lung cancer
por: Ren, Yijiu, et al.
Publicado: (2020)

Safety and feasibility of robotic-assisted thoracic surgery after neoadjuvant chemoimmunotherapy in non-small cell lung cancer
por: Zeng, Jun, et al.
Publicado: (2023)

Efficacy and Safety of Neoadjuvant Targeted Therapy vs. Neoadjuvant Chemotherapy for Stage IIIA EGFR-Mutant Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Chen, Dong, et al.
Publicado: (2021)

Erratum: Safety and feasibility of robotic-assisted thoracic surgery after neoadjuvant chemoimmunotherapy in non-small cell lung cancer
Publicado: (2023)

Assessment of Calcium Score Cutoff Point for Clinically Significant Aortic Stenosis on Lung Cancer Screening Program Low-Dose Computed Tomography—A Cross-Sectional Analysis
por: Klein-Awerjanow, Kaja, et al.
Publicado: (2023)

Genetic changes of non-small cell lung cancer under neoadjuvant therapy
por: Warth, Arne, et al.
Publicado: (2016)

Neoadjuvant therapy gains FDA approval in non-small cell lung cancer
por: Leal, Ticiana A., et al.
Publicado: (2022)

Surgery after neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer
por: Huynh, Caroline, et al.
Publicado: (2021)

Impacts of additional cycles of neoadjuvant immunotherapy on surgery in non‐small‐cell lung cancer
por: Chen, Jiawei, et al.
Publicado: (2023)

Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study
por: Undrunas, Aleksandra, et al.
Publicado: (2022)

Neoadjuvant gefitinib therapy: a potential standard therapy for non-small cell lung cancer
por: Nishida, Tomoki, et al.
Publicado: (2022)

Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations
por: Liu, Wenliang, et al.
Publicado: (2022)

Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy?
por: Zhang, Zhenyang, et al.
Publicado: (2020)

Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic Activity
por: Predina, Jarrod D., et al.
Publicado: (2021)

Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer
por: Shi, Xiaoshun, et al.
Publicado: (2021)

The safety and efficacy of neoadjuvant programmed death 1 inhibitor therapy with surgical resection in stage IIIA non-small cell lung cancer
por: Wang, Jiangfeng, et al.
Publicado: (2021)

Neoadjuvant immunotherapy in resectable non-small-cell lung cancer
por: Chen, Lanyi Nora, et al.
Publicado: (2023)

Prognostic factors in potentially resectable stage III non-small cell lung cancer receiving neoadjuvant treatment—a narrative review
por: Calvo, Virginia, et al.
Publicado: (2021)

Use of Pralsetinib as Neoadjuvant Therapy for Non-Small Cell Lung Cancer Patient With RET Rearrangement
por: Zhou, Ning, et al.
Publicado: (2022)

Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series
por: Hu, Yan, et al.
Publicado: (2022)

Spatial metabolomics for evaluating response to neoadjuvant therapy in non‐small cell lung cancer patients
por: Shen, Jian, et al.
Publicado: (2022)

Neoadjuvant Therapy and Factors Influencing Survival in Locally Advanced Non-Small Cell Lung Cancer
por: Ebinç, Senar, et al.
Publicado: (2023)

Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery
por: Shin, Sumin, et al.
Publicado: (2020)

Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable NSCLC
por: Lee, Jay M., et al.
Publicado: (2021)

Open lung biopsy performed in idiopathic pulmonary fibrosis is a safe procedure
por: Marjański, Tomasz, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8fpocd05mp5bt5k6r773age41v